![richard pester richard pester](https://fr.web.img6.acsta.net/pictures/15/03/17/10/08/146016.jpg)
He is ranked by Google Scholar for his areas of research including: cell cycle (#1), prostate cancer, Oncology and Breast cancer. Pestell's work has more than 82900 citations and an H-index of 150, i10 index 471. Pestell with Laura Bush, Andrea Jung, and Kathleen Walas of Avon Products, Inc. He exited CytoDyn in July 2019 and is currently member of the Wistar Institute Cancer Center Philadelphia and Blumberg Distinguished Professor.
#RICHARD PESTER TRIAL#
As the Chief Medical Officer, he established the company’s cancer clinical trial for the use of a CCR5 inhibitor (leronlimab) and FDA fast track designation in May 2019. In January 2019, Pestell was named Vice Chairman of the Board of the CytoDyn, Inc., which acquired his prior company, ProstaGene, in November 2018. He was called to give testimony to the Committee on Appropriations for the United States Senate in 2009. He was the Founding Director for the Delaware Valley Institute for Clinical and Translational Science. įrom 2005 to 2015, Pestell was Director of the Sidney Kimmel Cancer Center in Philadelphia, Pennsylvania, and Executive Vice President of Thomas Jefferson University. In 2003, he was also named President of the US branch of the International Network for Cancer Treatment and Research. Pestell led the effort for renewal of the National Cancer Institute designation, and founded the Capital Breast Care Center with Andrea Jung of the Avon Foundation. During this tenure, he also served as Associate Vice President of the Georgetown University Medical Center, at the Georgetown University School of Medicine. and Charlotte Gragnani Endowed Chair, and Chairman of the Department of Oncology at the Georgetown University Medical Center. In 2002, Pestell was named Director of the Lombardi Cancer Center, the Francis L. Pestell served as Chair of the Division of Endocrine-Dependent Tumor Biology at the Albert Einstein Cancer Center. He became an Associate Professor, and Professor, in the Departments of Medicine and Developmental and Molecular Biology at the Albert Einstein College of Medicine in New York. Pestell was recruited as an Assistant Professor to the Department of Molecular Medicine at Northwestern University's Feinberg School of Medicine in Chicago, Illinois. He became a postdoctoral clinical and research fellow in medicine at the Massachusetts General Hospital and a postdoctoral research fellow in medicine at Harvard Medical School in 1991. He was the recipient of both the Neal Hamilton Fairley Fellowship, and the Winthrop Fellowship of the Royal Australian College of Physicians. in 1997 from the University of Melbourne. He was awarded the Fellow of the Royal Australian College of Physicians (FRACP) in 1989. He conducted clinical training in internal medicine, oncology and endocrinology. He attended the University of Western Australia School of Medicine, receiving his M.B.B.S. Ī native of Perth, Western Australia, Pestell attended Christ Church Grammar School. Pestell was appointed an Officer of the Order of Australia in the 2019 Queen's Birthday Honours for distinguished service to medicine and medical education. He was previously Executive Vice President of Thomas Jefferson University and Director of the Sidney Kimmel Cancer Center of Thomas Jefferson University. Pestell AO is an Australian oncologist and endocrinologist who is Distinguished Professor, Translational Medical Research, and the President of the Pennsylvania Cancer and Regenerative Medicine Research Center at the Baruch S. Albert Einstein Cancer Center at Albert Einstein College of Medicine.Lombardi Comprehensive Cancer Center at Georgetown University Medical Center.Sidney Kimmel Cancer Center at Thomas Jefferson University.
![richard pester richard pester](https://thelawyer.imgix.net/content/uploads/2018/04/24173443/David-Pester-crop-300x.jpg)
![richard pester richard pester](https://i.pinimg.com/originals/2d/60/e9/2d60e9ee49a8272f26366379c3c9376f.jpg)